PLAU and prostate cancer: HDAC1 could induce the activation of urokinase-type plasminogen activator (uPA), matrix metalloprotease-1 (MMP-1) and MMP-2, but suppressed E-cadherin in order to accelerate the invasion and migration of prostate cancer cells (36–38).